C29H28ClF3N6O
Neat
569.0
-20°C
Room Temperature
Ponatinib hydrochloride; 1114544-31-8; Iclusig; AP 24534 hydrochloride; AP24534 HCL; 96R6PU3D8J; AP-24534 HCl; CHEBI:191940; DTXSID50149655; RefChem:58012; DTXCID0072146; 3-(2-(Imidazo(1, 2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide monohydrochloride; Benzamide, 3-(2-Imidazo(1, 2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1-Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)-, Hydrochloride (1:1); Ponatinib HCl; Ponatinib Mono-hydrochloride; Ponatinib hydrochloride [USAN]; Ponatinib (HCl salt); Ponatinib (hydrochloride); 3-(imidazo[1 and 2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide hydrochloride; 1114544-31-8 (HCl)
3-(2-imidazo[1 and 2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide;hydrochloride
InChI=1S/C29H27F3N6O.ClH/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37;/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39);1H